Related by context. All words. (Click for frequent words.) 71 AdVac ® 69 TransVax tm 68 TransVax TM 68 Vaxfectin TM formulated 68 TransVax ™ 67 AERAS-#/Crucell Ad# 67 SynCon ™ DNA 67 Vaxfectin R formulated 67 SynCon TM DNA 67 recombinant hepatitis B 67 Vaxfectin 67 SynCon 67 CMV vaccine 67 Trastuzumab DM1 67 NPC 1C 66 DepoVax TM 66 plasmid DNA vaccine 66 Modified Vaccinia Ankara MVA 66 Thiovir 66 SCIB1 66 TLR9 agonist 66 MT#/MEDI-# 66 HEPLISAV TM hepatitis B 66 OncoVex 66 novel therapeutic antibodies 66 volociximab 65 Bayer HealthCare Onyx Pharmaceuticals 65 investigational hepatitis B 65 immunotherapeutic vaccine 65 Multimeric 65 Deforolimus 65 staphylococcal vaccine 65 GRNVAC1 65 MKC# MT 65 Immunotherapeutic 65 ChronVac C R 65 dose intramuscular 65 Albuferon albinterferon alfa 2b 65 PF # [002] 65 GVAX ® 64 Juvaris BioTherapeutics 64 accumulate preferentially 64 Rigel R# 64 Archexin 64 DermaVir 64 AAG geldanamycin analog 64 dimebon latrepirdine 64 cathepsin K inhibitor 64 ONCONASE R 64 DermaVir Patch 64 PrevOnco 64 SynCon TM 64 MVA#A 64 PSMA ADC 64 mda 7 64 Vaxfectin ® 64 Initiates Phase II 64 therapeutic monoclonal antibody 64 Monoclonal antibody 64 personalized dendritic 64 Angiocept 64 IMA# 64 anti botulism antibody 64 semi synthetic lipoglycopeptide 64 selective orally bioavailable 64 Syncria albiglutide 64 PDE4 inhibitor 64 OvaRex R 64 M# rationally 64 drug conjugates ADCs 64 Pertuzumab 64 Sphingomab TM 63 Neuvenge 63 IMC #B 63 Zemplar Capsules 63 THR beta agonist 63 OMP #M# 63 plasmid DNA pDNA 63 YONDELIS 63 Alfacell proprietary ribonuclease 63 human IgG1 monoclonal 63 Neugene 63 MCSP respectively 63 virosome 63 Novavax VLP 63 attach auristatin 63 targeted antifolate 63 prepandemic 63 AERAS 63 LEAPS TM 63 Onconase 63 HEPLISAV ™ 63 Novavax VLP vaccine 63 Phase Ib II 63 cytotoxic T lymphocyte 63 immuno therapeutic 63 evaluating tivozanib 63 OncoVEX 63 MVA nef 63 recombinant subunit vaccine 63 SinuNase ™ 63 MAGE A3 ASCI 63 Chimigen TM 63 Universal Flu Vaccine 63 DepoVax 63 Adjuvanted 63 preclinically 63 agonistic human 63 Spiegelmer ® 63 Aflibercept 63 recombinant influenza 63 PENNVAX B 63 ChimeriVax JE 63 RhuDex R 63 MVA BN R 63 Vertex hepatitis C 63 non nucleoside inhibitor 63 Tesmilifene 63 Lisofylline LSF 62 Merck Suspends Lobbying 62 anti CD3 monoclonal 62 XOMA 3AB 62 delipidation 62 peptibody 62 Vitaxin 62 recombinant PSMA vaccine 62 kidney urologic 62 BiTE R 62 AKT inhibitor 62 H#N# VLP vaccine 62 oral prodrug 62 immunotherapeutic approaches 62 Gleevec resistant 62 rPA anthrax vaccine 62 IIa clinical 62 oral picoplatin 62 Factor VIIa 62 Phase 2a clinical trials 62 investigational integrase inhibitor 62 TransVax 62 Crofelemer budesonide foam 62 GeoVax vaccine 62 TOCOSOL Camptothecin 62 using Crucell PER.C6 62 taxane derivative 62 CPL Biologicals 62 CEQ# 62 novel VDA molecule 62 TBC# 62 PANVAC VF 62 trivalent influenza vaccine 62 relapsed MM 62 PNT# 62 investigational protease inhibitor 62 Liposomal 62 proteasome inhibitor 62 trivalent seasonal flu 62 Blinatumomab 62 DPX Survivac 62 Tykerb lapatinib 62 Glaxo cervical cancer 62 midstage clinical 62 DEB# 62 acyclovir Lauriad R 62 therapeutic monoclonal antibodies 62 HyperAcute 62 Panzem NCD 62 LymphoStat B belimumab 62 Modified Vaccinia Ankara 62 humanised monoclonal antibody 62 oncolytic virus therapies 62 NOX E# 62 Personalized Immunotherapy 62 humanized therapeutic 62 Diamyd ® 62 Kahalalide F 62 candidate REP# 62 Glufosfamide 62 Temsirolimus 62 TLR7 agonist 62 selective estrogen receptor modulator 62 ® bortezomib 62 tetravalent vaccine 62 Listeria vaccine 62 midstage trials 62 GVAX R 62 Omacetaxine 62 TLR9 agonist IMO 62 CELVAPAN H#N# 62 pharmacogenomic translational research 62 fully liquid pentavalent 62 PEGylated interferon 62 adecatumumab MT# 62 mertansine 62 Granulocyte Colony Stimulating Factor 62 Immunotherapeutics 62 VitiGam TM 62 Submits IND 62 Maribavir 61 Avian Influenza Vaccine 61 Micromet BiTE 61 Alferon N 61 HCD# [002] 61 PDE# inhibitors 61 NS5B polymerase 61 peptide antigens 61 Xanafide 61 monoclonal antibody mAb 61 EndoTAGTM 1 61 PORxin TM 61 HuLuc# 61 CB2 selective receptor agonist 61 anticancer therapeutics 61 carbohydrate polymer 61 Vaccine Adjuvant 61 Anidulafungin 61 HGS# 61 fusion enhancers 61 BHT DNA 61 cynomolgus macaques 61 Valortim TM 61 Pandemic Flu Vaccine 61 prophylactic vaccine 61 nucleotide analog 61 orally dosed 61 vemurafenib 61 FluCide 61 telomerase therapeutic 61 next generation URAT1 61 Pandemic Influenza Vaccine 61 tetravalent dengue vaccine 61 VIR# 61 VAX# 61 PORxin TM platforms 61 recombinant protective 61 SuperAntibody 61 Sanofi Pasteur ALVAC canary 61 Vaxfectin TM 61 CG# [003] 61 commercialize CorMedix drug 61 HCV RNA polymerase 61 nucleoside analog 61 initiate multicenter 61 rotavirus shingles 61 RhuDex ® 61 gastro intestinal inflammation 61 tramiprosate Alzhemed TM 61 conserved antigens NP 61 HGS ETR2 61 CBLC# 61 GLP toxicology studies 61 non porcine pancreatic 61 herpes simplex viruses 61 XL# anticancer compounds 61 Acetavance TM intravenous acetaminophen 61 PhG alpha 1 61 receptor tyrosine kinase inhibitor 61 Elvitegravir 61 evaluating satraplatin 61 TELINTRA R 61 CCR5 mAb 61 Annamycin 61 PREFLUCEL 61 CD8 + cytotoxic 61 MKC# MKC# PP 61 GeoVax HIV AIDS 61 Systemic Delivery 61 HEPLISAV TM 61 siRNA therapeutic 61 Maxy G# 61 Ostabolin C TM 61 Quinamed 61 Vaccine Protects Against 61 DepoVax ™ vaccine 61 intradermal vaccine 61 indibulin 61 Silodosin 61 IMiDs ® 61 NS5b 61 SAR# [002] 61 non nucleoside HCV 61 FLU v 61 subunit vaccine 61 Empatic ™ 61 RiVax 61 Oxytrex TM 61 ZFP Therapeutics 61 PD LID 61 BioVant 61 Olaparib 61 humanized monoclonal antibodies 61 Pimavanserin 61 RhuDex 61 drug figitumumab 61 nanoviricides 61 Initiates Enrollment 61 Intercell Japanese Encephalitis 61 VRX# [001] 61 inactivated influenza 61 azilsartan medoxomil 60 GSK# [002] 60 tubulin inhibitor 60 galiximab 60 Phase #b/#a clinical 60 lipid nanoparticle 60 Anavex #-# 60 Antibody Discovery 60 targeted radiotherapeutic 60 Anticalins R 60 subcutaneous PRO 60 Nasal spray flu 60 AFREZZA TM 60 BRAF inhibitor 60 AFFITOME R 60 Vidofludimus 60 microsomal triglyceride transfer 60 Panzem 60 ENMD # 60 cMET 60 Daclizumab 60 multicenter Phase II 60 BioThrax Anthrax Vaccine Adsorbed 60 ImmunoGen TAP technology 60 ASONEP 60 world safest multivalent 60 Aptamer 60 recombinant antibodies 60 Virulizin ® 60 Submits Biologics License Application 60 Achieves Primary Endpoint 60 GLPG# 60 DNA plasmids 60 triggers apoptosis programmed 60 epigenetic therapies 60 OvaRex ® MAb 60 MVA BN 60 Tuberculosis Vaccine 60 tetravalent 60 CYT# potent vascular disrupting 60 Safinamide 60 torezolid 60 Cathepsin S 60 FluINsure 60 SynCon ™ 60 valent pneumococcal 60 Nitazoxanide 60 Plasmid DNA 60 PLX MS 60 Nanobody 60 Begins Dosing 60 biologic therapeutics 60 SPL# Gel vaginal microbicide 60 albiglutide 60 Bazedoxifene 60 Degarelix 60 capsular polysaccharide 60 tremelimumab 60 Bosutinib 60 Janus kinase 60 novel oral anticoagulant 60 HCV polymerase 60 thiazolides 60 HuMax TAC 60 p# biomarker 60 intranasal influenza 60 CD4 monoclonal antibody 60 Allovectin 7 60 cancer immunotherapies 60 novel peptide 60 pharmacokinetic PK study 60 refractory prostate cancer 60 Vacc 4x 60 Tarceva TM 60 EndoTAG 60 Initiates Phase III 60 MVA BN ® 60 ribonucleotide reductase clinically validated 60 Oral NKTR 60 ALS #-# 60 Staphylococcus aureus Polysaccharide Conjugate 60 potent recombinant 60 histone deacetylase HDAC 60 proprietary attenuated Listeria 60 Pancreate 60 anionic backbone 60 progressive metastatic prostate 60 demonstrated antitumor activity 60 GelSite R polymer 60 Intercell vaccine 60 Prodarsan ® 60 OvaRex 60 clinical trials Archexin 60 immunotherapeutics 60 Pre Exposure Prophylaxis 60 Micromet proprietary BiTE 60 novel chimeric natriuretic 60 generation PNP inhibitor 60 Vectibix panitumumab 60 Phase Ib IIa 60 HuMax CD#b 60 Initiates Clinical 60 cardio metabolic diseases 60 initiated Phase Ib 60 Hsp# Inhibitor 60 selectively inhibit replication 60 ixabepilone 60 Talabostat 60 5 HT2A inverse 60 MVA MUC1 IL2 60 Evoltra ® 60 torezolid phosphate 60 oral antiviral 60 Initiates Clinical Trial 60 Small Modular SMIP 60 RAV# 60 rxRNA 60 TLR agonists 60 targeting miR 60 dasatinib Sprycel 60 rhMBL 60 investigational monoclonal antibody 60 delta opioid receptor 60 Ustekinumab 60 Vaxfectin R adjuvant 60 novel immunotherapeutic 60 Entry Inhibitor 60 Pruvel TM 60 chimeric monoclonal antibody 60 SUTENT ® 60 R#/MEM # 60 antigen rPA anthrax 60 ChronVac C ® 60 platform HDL Mimetic 60 preclinical efficacy 60 Enzastaurin 60 docetaxel Taxotere R 60 BIM #A# 60 PROSTVAC VF 60 IMPDH inhibitor 60 Phase #b/#a trial 60 XmAb 60 Phase 1b clinical trials 60 Phase Ib study 60 Vicriviroc 60 apricitabine ATC 60 OMP #R# 60 brivanib 60 trastuzumab emtansine T DM1 60 theranostic 60 SUCCEED trial 59 recombinant adeno associated 59 PNP inhibitor 59 Prodarsan R 59 VitiGam 59 Phase Ib clinical 59 evaluating mipomersen 59 receptor inhibiting monoclonal 59 liposomal formulation 59 RNA antagonists 59 Novel Therapeutic 59 Xcytrin R 59 trastuzumab Herceptin R 59 blinded randomized placebo controlled 59 Prodarsan 59 AFFiRiS 59 phase IIa clinical 59 Crucell genetically engineered 59 GW# [003] 59 Zolinza 59 Multiple Ascending Dose 59 Tofacitinib 59 protein tyrosine phosphatase 1B 59 Trofex TM 59 ragweed allergy immunotherapeutic 59 JAK inhibitor 59 Urocidin 59 antiangiogenic agent 59 VentiRx 59 Pfizer Selzentry 59 Darinaparsin 59 intranasal insulin product 59 lipopeptide 59 MDS AML 59 personalized immunotherapy 59 Japanese Encephalitis Vaccine 59 phosphatidylserine PS targeting 59 EGS# 59 reverse vaccinology 59 haemophilus influenza B 59 modified vaccinia Ankara 59 solid tumors ZYBRESTAT 59 Phase IIa proof 59 StemEx 59 Zalypsis 59 NEUGENE 59 FOLFOX6 chemotherapy regimen 59 Ad5FGF 4 59 HQK 59 adjuvanted H#N# 59 LymphoStat B TM 59 dSLIM 59 compound INCB# 59 vosaroxin 59 Omapro 59 novel peptides 59 Prostate AdenoCarcinoma Treatment 59 Trandolapril 59 IL# PE#QQR 59 streptococcal vaccine 59 Delafloxacin 59 Muraglitazar 59 Phase lll 59 immune modulating 59 commercialize OncoGenex lead 59 therapeutic peptide 59 Initiate Phase 59 Therapeutic Vaccine 59 GRNOPC1 contains 59 chemokine receptor 59 Fc fusion protein 59 IG HCR ;) CO 59 Talotrexin 59 pivotal bioequivalence 59 StaphVAX R 59 Xcellerex FlexFactory 59 Chimigen 59 gets USFDA nod 59 non nucleoside 59 dexpramipexole 59 dirucotide MBP# 59 monoclonal antibody MAb 59 BioNumerik 59 NTDDS 59 lumiliximab 59 CD# antibody [002] 59 valent pneumococcal conjugate vaccine 59 Telintra 59 Aganocide 59 EXPLORE Xa 59 Presents Preclinical 59 Imatinib mesylate 59 DepoVax ™ 59 investigational HCV polymerase 59 directed radiotherapeutic antibody 59 generation purine nucleoside 59 VLP vaccine 59 potent cytotoxic 59 vinca alkaloid 59 highly immunogenic 59 M2e 59 CCR5 inhibitor 59 Ocrelizumab 59 ATRA IV 59 Kinase Inhibitor 59 CD# CEA 59 immune stimulatory 59 Sanaria vaccine 59 oral immunomodulatory 59 M2 subunit 59 PrevOnco ™ 59 idiotype vaccines 59 Denufosol 59 Telatinib 59 P#X# antagonist 59 Belerofon 59 ARRY # 59 Fodosine 59 Twinrix 59 beta 1a 59 neuraminidase inhibitor 59 tkRNAi 59 Exelixis compounds 59 Phase #b/#a 59 Selzentry maraviroc 59 AGS PSCA 59 Chemokine 59 Phase III multicenter 59 NEUGENE R 59 thalidomide Thalomid 59 anti idiotype 59 Virosome Biologicals 59 motesanib diphosphate 59 includes TOLAMBA TM 59 Dalbavancin 59 Sphingomab 59 Panzem R NCD 59 Phase 1a clinical 59 molecular chaperone regulator 59 drug GLPG# 59 virus HCV protease inhibitor 59 Saxagliptin 59 Laquinimod 59 prophylactic vaccines 59 elotuzumab 59 A3 adenosine receptor 59 potent suppressor 59 Simulect 59 cholesteryl ester transfer 59 initiate Phase 2b 59 5 HT2A serotonin 59 GV# [001] 59 sapacitabine CYC# 59 Tocosol 59 CEA CD# Her2 59 fosbretabulin 59 metaglidasen 59 bavituximab monotherapy trial 59 alpha#beta# integrin 59 NEUGENE antisense 59 selective immunoproteasome inhibitor 59 Japanese Encephalitis vaccine 59 recurrent metastatic ovarian cancer 59 Prostate Cancer Vaccine 59 non peptidic protease 59 alvespimycin 59 radiation sensitizer 59 Ankara MVA 59 INCB# [001] 59 Aplidin R 59 androgen receptor antagonist 59 Ixabepilone 59 DOS# 59 transgenic mouse models 59 Potelligent Technology 59 3TC lamivudine 59 Phase IIIb clinical 59 Vaccine Shows Promise 58 Tarvacin 58 phase IIb clinical 58 isotype 58 Elotuzumab 58 Successfully Completes Phase 58 VEGFR2 inhibitor 58 confirmatory pivotal 58 investigational humanized monoclonal antibody 58 Valortim R 58 Curaxin 58 IMiDs R 58 Mosquirix 58 Poly ICLC 58 AVAX AC Vaccine 58 intranasal formulation 58 Tarvacin Anti Viral 58 Completes Patient Enrollment 58 Curaxin CBLC# 58 HTS assay 58 Panzem R 58 IIa trial 58 humanised antibody 58 HGS ETR1 mapatumumab 58 IMC A# 58 class mGluR5 inhibitor 58 trastuzumab DM1 58 GRN# 58 Lovaxin C 58 Budesonide foam crofelemer 58 Elacytarabine 58 phase IIb trial 58 ImmunoCellular Therapeutics 58 Interferon beta 58 Shows Promise Against 58 Atripla combines 58 CCX# 58 CYT# NicQb 58 orally administered inhibitor 58 BRAF kinase 58 immune modulator 58 lintuzumab SGN 58 nilotinib Tasigna 58 Files IND 58 PROVENGE ® 58 developing TB4 58 vinorelbine tartrate 58 davalintide 58 phase Ib clinical 58 vidofludimus 58 AdhTAP 58 REGEN trial 58 antisense therapies 58 OMAPRO ™ 58 anticoagulant reversing agent 58 somatostatin analog 58 BCR ABL inhibitors 58 including eniluracil ADH 58 serogroup B 58 Provenge prostate cancer 58 ART# 58 Gleevec imatinib mesylate 58 LHRH antagonist 58 Lixivaptan 58 Kosan dependence 58 Cannabinor 58 mitogen activated ERK kinase 58 XOMA 3AB biodefense 58 ORAL Solo 58 Canvaxin TM 58 Cardiotoxicity 58 pertuzumab 58 inhibit replication 58 HepeX B TM 58 Vaccinex 58 selective modulator 58 hypoxia activated prodrug 58 KRAS mutant 58 First Patient Dosed 58 targeting PCSK9 58 Zybrestat 58 phase Ib 58 reversible inhibitor 58 TLR8 58 5 fluorouracil leucovorin 58 R roscovitine 58 bendamustine HCl 58 protein kinase inhibitor 58 candidate deforolimus 58 NY ESO 58 RAS MAPK pathway 58 lorvotuzumab mertansine 58 adrenergic regulation 58 SMT C# 58 oncolytic virus 58 SparVax ™ 58 reslizumab 58 HuCAL antibodies 58 INS# [001] 58 BLyS specific 58 secretory phospholipase A2 58 Nasdaq ACHN 58 antisense inhibitors 58 CCR5 receptor antagonist 58 trastuzumab DM1 T DM1 58 neratinib 58 microtubule inhibitor 58 IRX 2 58 BiTE 58 SMIP 58 MSCRAMM ® 58 Inotek Pharmaceuticals Corporation 58 Kevetrin TM 58 receptor inhibitor 58 maturation inhibitor 58 Hedgehog inhibitor 58 tumor antigen 58 Aidsvax 58 Allovectin 7 R 58 dasatinib Sprycel ® 58 erlotinib Tarceva ® 58 Epothilones 58 elvitegravir 58 Anticalin R 58 Phase Ib clinical trials 58 TKB# 58 Hematide ™ 58 Etubics 58 rhFVIIa 58 Cloretazine ® 58 PDE# 58 humanized antibody 58 Tesetaxel 58 systemic RNAi 58 deCODE AF TM 58 Empatic TM 58 NeuVax 58 Aplidin 58 biobetter 58 intranasal vaccines 58 aurora kinase inhibitor 58 CRLX# 58 introduced NEUGENE 58 phase IIb III 58 phase IIa 58 romazarit 58 highly selective endothelin 58 MMR Measles Mumps Rubella 58 Aeolus Pharmaceuticals Announces 58 immunotherapeutic agent 58 HCV antiviral 58 investigational therapies 58 genetically engineered recombinant protein 58 bortezomib Velcade R 58 immunomodulator 58 REG2 58 JZP 58 hepatoma 58 CTAP# Capsules 58 Anti VEGF 58 multivalent vaccine 58 aldehyde dehydrogenase ALDH2 deficiency 58 mGluR5 antagonists 58 Cytolin R 58 immatics 58 BEZ# 58 specific lectin receptors 58 ThermoDox ® clinical 58 CoVal TM fusion 58 topoisomerase II inhibitor 58 paclitaxel poliglumex 58 Proellex TM 58 albiglutide currently 58 targeting CD# 58 Wellstat 58 Lpathomab 58 Antibody Drug Conjugate 58 initiate Phase Ib 58 XL# XL# XL# XL# 58 Saforis 58 Elagolix 58 enhance ApoA 58 cyclin dependent kinase inhibitor 58 RNAi Therapeutic 58 candidates Azedra TM 58 Amplimmune 58 INxin TM 58 DCVax R 58 targeted anticancer therapies 58 WX UK1 58 lentiviral 58 Belimumab 58 Valtropin 58 Lu AA# 58 Cardio Vascu Grow 58 ToGA 58 commercializing oxidized glutathione 58 CML CP 58 deforolimus 58 PI3K/Akt pathway inhibitor 58 trodusquemine 58 CYT# vascular disrupting 58 INTEGRILIN R eptifibatide Injection 58 reverse transcriptase inhibitor 58 ASONEP ™ 58 ALN HTT 58 NV1FGF 58 multicenter randomized placebo controlled 58 Respiratory Syncytial Virus RSV 58 Protexia R 58 vivo validation 58 CCR1 58 farletuzumab 58 adenovirus serotype 58 solanezumab 58 HIV integrase inhibitor 58 Phase IIb clinical trials 58 gemcitabine Gemzar ® 58 Tarvacin TM 58 interleukin IL -# 58 novel orally administered 58 Fx #A 58 virotherapy 58 CHAMPION PCI 58 transgenic rats 58 UPLYSO 58 Ceflatonin 58 antibody MAb 58 Diamyd R 58 pharmacodynamic markers 58 Ragweed Allergy 58 oral Janus kinase 58 pathophysiological effects 58 miconazole Lauriad ® 58 IAP inhibitor 58 Litx 58 Submits Response 58 ZYBRESTAT fosbretabulin 58 Antitumor 58 Vical Vaxfectin R 58 MF# adjuvanted 58 NSABP C 58 SparVax 58 quadrivalent human papillomavirus 57 CCR5 antagonist 57 antimitotic 57 IgG1 antibody 57 HDL Mimetic Peptide 57 recombinant biopharmaceutical 57 immunotoxin 57 gastrin analogue TT 57 TLR8 agonist 57 Phase #/#a clinical 57 bOPV 57 oral proteasome inhibitor 57 polyglutamate 57 dependent cellular cytotoxicity 57 KNS # 57 REGiMMUNE 57 cytokine refractory 57 PEG IFN 57 recombinant vaccines 57 live attenuated intranasal 57 JAK inhibitors 57 Oglemilast 57 budesonide foam 57 Receptor TLR 57 dacetuzumab 57 TORISEL TM 57 tolevamer 57 ALN VSP Phase 57 oral deforolimus 57 CYP#A# CYP#D# 57 Dose Escalation 57 Combination REOLYSIN R 57 triphendiol 57 Oral Calcitonin 57 Nanobody ® 57 NanoViricides 57 HDL Selective Delipidation 57 AN# novel 57 PRT# 57 Phase IIB 57 topical microbicide 57 MGd 57 Aurora Kinase 57 sulfonylhydrazine class 57 JAK3 57 ALK inhibitors 57 AAV vector 57 XmAb# 57 MAXY VII 57 Bellicum 57 trial evaluating PRX# 57 inverse agonist 57 Drug Shows Promise 57 nalbuphine ER 57 YONDELIS R 57 multitargeted 57 RTP #i 57 nucleoside reverse transcriptase inhibitor 57 DGAT 57 TRIOLEX HE# APOPTONE HE# 57 Phase IIA 57 immune modulatory 57 murine monoclonal antibody 57 romidepsin novel 57 myelofibrosis polycythemia vera 57 Arcelis ™ 57 Phase 2b Trial 57 nanoviricide drug 57 Bafetinib 57 Hiberix 57 StemEx R 57 HuMax Inflam 57 Sudhir Agrawal D.Phil 57 Epiphany Biosciences 57 Nasdaq MITI biopharmaceutical 57 bortezomib Velcade 57 Xelox 57 Receives Orphan Drug Designation 57 Uvidem 57 phase IIb study 57 Initiates Phase 2b 57 K ras mutations 57 Solulin 57 NU# direct 57 antibody MT# 57 Tumour Vascular Disrupting Agent 57 ASX PGL 57 quadrivalent HPV vaccine 57 replicon 57 negative allosteric modulator 57 Pentad TM 57 Romidepsin 57 PEG irinotecan 57 Files Investigational 57 Novolimus 57 PSN# [002] 57 SinuNase TM 57 HuMax CD4 57 metabolite identification 57 dose escalation clinical 57 IIa trials 57 nasal powder 57 Teriflunomide 57 treatment naive genotype 57 initiate Phase IIb 57 outlicensed 57 Receptos 57 OvaRex MAb 57 humanized monoclonal 57 CCR2 antagonists 57 pralatrexate injection folate analogue 57 Acute myelogenous leukemia 57 Phase #/#a trial 57 evaluating T DM1 57 INSPIRE Trial Phase III 57 Locked Nucleic Acid LNA 57 fusion inhibitor 57 Celtura 57 gamma secretase inhibitor 57 TÎ ² 4 57 MyVax 57 Plicera 57 PEGylated 57 ficlatuzumab 57 Scancell 57 Forodesine 57 Transfersome ® 57 oncolytic 57 Altastaph 57 recombinant interferon